What does SUPERCLINIC do?

SUPERCLINIC is an advertising agency in Montigny-le-Tilleul. Private Limited, started on 16 September 2022, 1 establishment.

What is the address of SUPERCLINIC?

The registered office of SUPERCLINIC is located at Rue Chêne Bonnet 150, 6110 Montigny-le-Tilleul.

Is SUPERCLINIC still active?

Yes. According to the CBE (17 September 2026) SUPERCLINIC is active, legal situation “Normale toestand”, started on 16 September 2022.

Is SUPERCLINIC registered on Peppol?

Yes, SUPERCLINIC is registered on the Peppol network with ID 0208:0790893953.

What is the enterprise number of SUPERCLINIC?

The enterprise number of SUPERCLINIC is BE0790893953.

When was SUPERCLINIC founded?

SUPERCLINIC was founded on 16 September 2022.

Who are the directors of SUPERCLINIC?

According to the 2025 annual accounts, the directors of SUPERCLINIC are: FRANCOIS CLAUDE GERY DAUBRESEE.

Is SUPERCLINIC a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 September 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did SUPERCLINIC make in 2025?

SUPERCLINIC posted a profit after taxes of € 3,404 in financial year 2025.

What is the revenue of SUPERCLINIC?

In its most recent annual accounts (2025), SUPERCLINIC reported revenue of € 0.

SUPERCLINIC (Private Limited) - Montigny-le-Tilleul

Dossier SUPERCLINIC, printed on 17 September 2026 from databakkes.be/en/0790893953/superclinic. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

SUPERCLINIC from Montigny-le-Tilleul, company number BE0790893953, closed financial year 2025 with a result of € 3,404 after tax. For that financial year SUPERCLINIC recorded revenue of € 0 and equity of € 19,559. Compared with financial year 2024, the result moved from € 5,019 to € 3,404. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.

What it is worth Healthy

€ 19,559

▼ 20% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 3,404

▼ 32% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 16,663

▲ 38% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 8,424 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,833

▲ 2% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 3,725

▼ 43% vs 2024

€ 2,967 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 7,656

▲ 209% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 10,128

▲ 25% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 18,349 Gross margin 2022: € 18,349 First fiscal year in the series	€ 13,770 Gross margin 2023: € 13,770 ▼ 25% vs 2022 (€ 18,349) Unfavourable step	€ 12,495 Gross margin 2024: € 12,495 ▼ 9% vs 2023 (€ 13,770) Unfavourable step	€ 10,245 Gross margin 2025: € 10,245 ▼ 18% vs 2024 (€ 12,495) Unfavourable step	▼ 18%
Profit after taxes	€ 11,840 Profit after taxes 2022: € 11,840 First fiscal year in the series	€ 5,719 Profit after taxes 2023: € 5,719 ▼ 52% vs 2022 (€ 11,840) Unfavourable step	€ 5,019 Profit after taxes 2024: € 5,019 ▼ 12% vs 2023 (€ 5,719) Unfavourable step	€ 3,404 Profit after taxes 2025: € 3,404 ▼ 32% vs 2024 (€ 5,019) Unfavourable step	▼ 32%
Equity	€ 13,840 Equity 2022: € 13,840 First fiscal year in the series	€ 19,559 Equity 2023: € 19,559 ▲ 41% vs 2022 (€ 13,840) Favourable step	€ 24,578 Equity 2024: € 24,578 ▲ 26% vs 2023 (€ 19,559) Favourable step	€ 19,559 Equity 2025: € 19,559 ▼ 20% vs 2024 (€ 24,578) Unfavourable step	▼ 20%
Total debts	€ 17,071 Total debts 2022: € 17,071 First fiscal year in the series	€ 31,335 Total debts 2023: € 31,335 ▲ 84% vs 2022 (€ 17,071) Unfavourable step	€ 18,432 Total debts 2024: € 18,432 ▼ 41% vs 2023 (€ 31,335) Favourable step	€ 29,933 Total debts 2025: € 29,933 ▲ 62% vs 2024 (€ 18,432) Unfavourable step	▲ 62%
Cash	€ 10,961 Cash 2022: € 10,961 First fiscal year in the series	€ 17,315 Cash 2023: € 17,315 ▲ 58% vs 2022 (€ 10,961) Favourable step	€ 12,050 Cash 2024: € 12,050 ▼ 30% vs 2023 (€ 17,315) Unfavourable step	€ 16,663 Cash 2025: € 16,663 ▲ 38% vs 2024 (€ 12,050) Favourable step	▲ 38%
Retained profit	€ 11,840 Retained profit 2022: € 11,840 First fiscal year in the series	€ 17,559 Retained profit 2023: € 17,559 ▲ 48% vs 2022 (€ 11,840) Favourable step	€ 22,578 Retained profit 2024: € 22,578 ▲ 29% vs 2023 (€ 17,559) Favourable step	€ 17,559 Retained profit 2025: € 17,559 ▼ 22% vs 2024 (€ 22,578) Unfavourable step	▼ 22%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 8,424 Dividend 2025: € 8,424 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 9,356 Bank debt 2023: € 9,356 Unchanged (€ 0) Unfavourable step	€ 6,590 Bank debt 2024: € 6,590 ▼ 30% vs 2023 (€ 9,356) Favourable step	€ 3,725 Bank debt 2025: € 3,725 ▼ 43% vs 2024 (€ 6,590) Favourable step	▼ 43%
Balance sheet total	€ 30,911 Balance sheet total 2022: € 30,911 First fiscal year in the series	€ 50,894 Balance sheet total 2023: € 50,894 ▲ 65% vs 2022 (€ 30,911) Unchanged	€ 43,010 Balance sheet total 2024: € 43,010 ▼ 15% vs 2023 (€ 50,894) Unchanged	€ 49,492 Balance sheet total 2025: € 49,492 ▲ 15% vs 2024 (€ 43,010) Unchanged	▲ 15%

Key figures of SUPERCLINIC, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SUPERCLINIC?

What happened at SUPERCLINIC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 25, 2026 New annual accounts for financial year 2025: profit of € 3,404 (▼ 32% vs 2024). Source: NBB ↗
Sep 16, 2022 New establishment in Montigny-le-Tilleul. KBO
2022 FRANCOIS CLAUDE GERY DAUBRESEE became a director. NBB
Sep 16, 2022 Start of the company according to the CBE. KBO

In short

From € 11,840 profit in 2022 to € 3,404 profit in 2025.

Paid € 14,127 in corporate taxes since 2022.

Best year ever: 2022, with € 11,840 profit.

Paid out € 8,424 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at SUPERCLINIC? We notify you, reason included.

Follow SUPERCLINIC

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

FRANCOIS CLAUDE GERY DAUBRESEE

SUPERCLINIC

Behind SUPERCLINIC is FRANCOIS CLAUDE GERY DAUBRESEE.

See the full network in the app

Directors

According to the 2025 annual accounts

FRANCOIS CLAUDE GERY DAUBRESEE

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Chêne Bonnet 150

6110 Montigny-le-Tilleul

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Greenwood Consult

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0790.893.953
VAT number: BE 0790.893.953
Registered office: Rue Chêne Bonnet 150, 6110 Montigny-le-Tilleul
Names & denominations: SUPERCLINIC
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 16 September 2022
Peppol: Active · Active since 14 Jan 2026
Contact: [email protected]
Activities · NACE: Activiteiten van reclamebureaus

View on CBE Public ↗ Annual accounts (NBB) ↗